Cargando…
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
Prostate cancer (PCa) is the second most diagnosed malignant neoplasm and is one of the leading causes of cancer-related death in men worldwide. Despite significant advances in screening and treatment of PCa, given the heterogeneity of this disease, optimal personalized therapeutic strategies remain...
Autores principales: | Davoudi, Fatemeh, Moradi, Afshin, Becker, Therese M., Lock, John G., Abbey, Brian, Fontanarosa, Davide, Haworth, Annette, Clements, Judith, Ecker, Rupert C., Batra, Jyotsna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547634/ https://www.ncbi.nlm.nih.gov/pubmed/37561382 http://dx.doi.org/10.1007/s11864-023-01121-z |
Ejemplares similares
-
Identification and Characterization of Alternatively Spliced Transcript Isoforms of IRX4 in Prostate Cancer
por: Fernando, Achala, et al.
Publicado: (2021) -
A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019) -
SWATH-MS Based Proteomic Profiling of Prostate Cancer Cells Reveals Adaptive Molecular Mechanisms in Response to Anti-Androgen Therapy
por: Liyanage, Chamikara, et al.
Publicado: (2021) -
Identification of Candidate mRNA Isoforms for Prostate Cancer-Risk SNPs Utilizing Iso-eQTL and sQTL Methods
por: Moradi, Afshin, et al.
Publicado: (2022) -
Candidate gene association studies: a comprehensive guide to useful in silico tools
por: Patnala, Radhika, et al.
Publicado: (2013)